Mammography screening is associated with more favorable breast cancer tumor characteristics and better overall survival: Case-only analysis of 3,739 Asian breast cancer patients.

Authors

null

Mikael Hartman

NUH, Singapore, Singapore

Mikael Hartman , Zi Lin Lim , Peh Joo Ho , Alexis Jiaying Khng , Yen Shing Yeoh , Amanda Tse Woon Ong , Benita Kiat Tee Tan , Ern Yu Tan , Su-Ming Tan , Geok Hoon Lim , Kiak Mien Veronique Tan , Jingmei Li

Organizations

NUH, Singapore, Singapore, Genome Institute of Singapore, Singapore, Singapore, National University Singapore, Singapore, Singapore, Genome Institute Singapore, Singapore, Singapore, National University of Singapore, Singapore, Singapore, Department of General Surgery, Singapore General Hospital, Singapore, Singapore, Tan Tock Seng Hospital-(Singapore), Singapore, Singapore, Changi General Hospital, Singapore, Singapore, Singapore, KK Women's and Children's Hospital, Singapore, Singapore, National Cancer Centre Singapore, Singapore, Singapore

Research Funding

Other

Background: Early detection of breast cancer (BC) through mammography screening (MAM) is known to reduce mortality. We examined the differential effect that mammography has on BC characteristics and overall survival and the sociodemographic determinants of MAM utilisation in a multi-ethnic Asian population. Methods: This study included 3,739 BC patients from the Singapore Breast Cancer Cohort (2010–2018). Self-reported socio-demographic characteristics were collected using a structured questionnaire. Clinical data were obtained through medical records. Patients were classified as screeners (last screening mammogram ≤two years before diagnosis), non-screeners (aware but did not attend or last screen > 2years) and those unaware of MAM. Associations between MAM behaviour (MB) and sociodemographic factors and MB and tumour characteristics were examined using multinomial regression. Ten-year overall survival was modelled using Cox regression. Results: Patients unaware of screening were more likely diagnosed with late stage (ORstage III vs stage I(Ref) [95%CI]:4.94[3.45-7.07], p < 0.001), high grade (ORpoorly- vs well-differentiated(reference): 1.53 [1.06-2.20], p = 0.022), nodal-positive, large size (OR> 5cm vs ≤2cm(reference): 5.06 [3.10-8.25], p < 0.001), and HER2-positive tumors (ORHER2-negative VS -positive(reference): 0.72[0.53-0.97], p = 0.028). Similar trends were observed between screeners and non-screeners with smaller effect sizes. Overall survival was significantly shorter than screeners in the both groups(non-screeners HR: 1.89 [1.22-2.94], p = 0.005; unaware HR: 2.90[1.69-4.98], p < 0.001). Non-screeners and those unaware were less health-conscious, older, of Malay ethnicity, less highly educated, of lower socioeconomic status, more frequently ever smokers and less physically active. Among screeners, there were more reported personal histories of benign breast surgeries or gynaecological conditions and positive family history of breast cancer. Conclusions: Mammography attendance is associated with more favourable BC characteristics and overall survival. Disparities in the utility of MAM services suggest that different strategies may be needed to improve MAM uptake.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Prevention

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr e22500)

DOI

10.1200/JCO.2022.40.16_suppl.e22500

Abstract #

e22500

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Barriers, facilitators, and strategies for improving breast cancer screening in Ukraine.

First Author: Ali Dzhemiliev

Abstract

2023 ASCO Annual Meeting

Beneficial effect of repeated participation in breast cancer screening upon survival.

First Author: Robert A. Smith

Abstract

2023 ASCO Annual Meeting

Impact of early mammography screening on time to diagnosis.

First Author: Cliff Rutter

First Author: Carla Zeballos Torres